Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

An embryo-derived peptide signal directs endosperm polarity in Arabidopsis.

Created on 04 Sep 2026

Authors

Audrey Creff, Jack Rhodes, Camille Salaün, Julien Larive, Vincent Bayle, Maialen Garmendia-Calvo, Emma Turley, Tatsuya Nobori, Duarte D Figueiredo, Benoit Landrein, Cyril Zipfel, Gwyneth Ingram

Published in

Science (New York, N.Y.). Volume 393. Issue 6815. Pages 1002-1008. Sep 03, 2026. Epub Sep 03, 2026.

Abstract

Angiosperm seed formation requires the coordinated development of the products of double fertilization-the embryo and the endosperm. The endosperm mediates efficient nutrient transfer from surrounding maternal tissues to the developing embryo. This function requires a polarized tissue organization, which manifests as early polar gene expression and polar cellularization dynamics. We show that the receptor kinase HAIKU2 (IKU2) acts in coordination with the transcription factor WRKY10/MINISEED3 (MINI3) to ensure robust endosperm polarity establishment through the activity of the homeodomain transcription factors WUSCHEL-RELATED HOMEOBOX 8 (WOX8) and WOX9. This process depends on egg cell fertilization and is mediated through the peptide PATHOGEN-INDUCED PEPTIDE-LIKE 7 (PIPL7), which acts as a potential IKU2 ligand. Our results reveal how a molecular paracrine dialog between the embryo and endosperm ensures optimal seed developmental coordination.

PMID:
42691177
Bibliographic data and abstract were imported from PubMed on 04 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement